These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 12296852

  • 1. C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis.
    Welch TR, Frenzke M, Witte D, Davis AE.
    Clin Exp Immunol; 2002 Oct; 130(1):43-8. PubMed ID: 12296852
    [Abstract] [Full Text] [Related]

  • 2. Evidence of a role for local complement expression in a murine model of progressive glomerulonephritis.
    Welch TR, Frenzke M, Witte D.
    Pediatr Res; 2000 Aug; 48(2):200-5. PubMed ID: 10926295
    [Abstract] [Full Text] [Related]

  • 3. C3 is central to the interstitial component of experimental immune complex glomerulonephritis.
    Welch TR, Blystone LW.
    Clin Immunol; 2005 Apr; 115(1):80-4. PubMed ID: 15870025
    [Abstract] [Full Text] [Related]

  • 4. Immune complex glomerulonephritis following bone marrow transplantation in C3 deficient mice.
    Welch TR, Blystone LW.
    PLoS One; 2008 Oct 06; 3(10):e3334. PubMed ID: 18836527
    [Abstract] [Full Text] [Related]

  • 5. Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridization.
    Abe K, Miyazaki M, Koji T, Furusu A, Nakamura-Kurashige T, Nishino T, Ozono Y, Harada T, Sakai H, Kohno S.
    Kidney Int; 2001 Jul 06; 60(1):137-46. PubMed ID: 11422745
    [Abstract] [Full Text] [Related]

  • 6. Shift of C3 deposition from localization in the glomerulus into the tubulo-interstitial compartment in the absence of secreted IgM in immune complex glomerulonephritis.
    Vaculik C, Rüger BM, Yanagida G, Hollemann D, Soleiman A, Losert UM, Chen J, Fischer MB.
    Clin Exp Immunol; 2008 Jan 06; 151(1):146-54. PubMed ID: 17991287
    [Abstract] [Full Text] [Related]

  • 7. Immune complex induced glomerular lesions in C5 sufficient and deficient mice.
    Falk RJ, Jennette JC.
    Kidney Int; 1986 Nov 06; 30(5):678-86. PubMed ID: 2946891
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Distinct tissue site-specific requirements of mast cells and complement components C3/C5a receptor in IgG immune complex-induced injury of skin and lung.
    Baumann U, Chouchakova N, Gewecke B, Köhl J, Carroll MC, Schmidt RE, Gessner JE.
    J Immunol; 2001 Jul 15; 167(2):1022-7. PubMed ID: 11441111
    [Abstract] [Full Text] [Related]

  • 11. Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis.
    Reiman R, Gerard C, Campbell IL, Barnum SR.
    Eur J Immunol; 2002 Apr 15; 32(4):1157-63. PubMed ID: 11932923
    [Abstract] [Full Text] [Related]

  • 12. Mesangial cell complement receptor 1-related protein y limits complement-dependent neutrophil accumulation in immune complex glomerulonephritis.
    Bao L, Wang Y, Chen P, Sarav M, Haas M, Minto AW, Petkova M, Quigg RJ.
    Immunology; 2009 Sep 15; 128(1 Suppl):e895-904. PubMed ID: 19740350
    [Abstract] [Full Text] [Related]

  • 13. Immune complex glomerulonephritis in C4- and C3-deficient mice.
    Quigg RJ, Lim A, Haas M, Alexander JJ, He C, Carroll MC.
    Kidney Int; 1998 Feb 15; 53(2):320-30. PubMed ID: 9461092
    [Abstract] [Full Text] [Related]

  • 14. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice.
    Sekine H, Reilly CM, Molano ID, Garnier G, Circolo A, Ruiz P, Holers VM, Boackle SA, Gilkeson GS.
    J Immunol; 2001 May 15; 166(10):6444-51. PubMed ID: 11342671
    [Abstract] [Full Text] [Related]

  • 15. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis.
    Ooi JD, Li M, Kourkoutzelos K, Yagita H, Azuma M, Holdsworth SR, Kitching AR.
    Nephrology (Carlton); 2015 Dec 15; 20(12):892-8. PubMed ID: 26043977
    [Abstract] [Full Text] [Related]

  • 16. Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. II. Clinicopathologic study of seven patients.
    Pardo V, Strauss J, Kramer H, Ozawa T, McIntosh RM.
    Am J Med; 1975 Nov 15; 59(5):650-9. PubMed ID: 128292
    [Abstract] [Full Text] [Related]

  • 17. Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formation.
    Ophascharoensuk V, Pippin JW, Gordon KL, Shankland SJ, Couser WG, Johnson RJ.
    Kidney Int; 1998 Aug 15; 54(2):416-25. PubMed ID: 9690208
    [Abstract] [Full Text] [Related]

  • 18. Interstrain variations in nephritogenicity of heterologous protein in mice.
    Iskandar SS, Jennette JC, Wilkman AS, Becker RL.
    Lab Invest; 1982 Mar 15; 46(3):344-51. PubMed ID: 6460898
    [Abstract] [Full Text] [Related]

  • 19. Decay-accelerating factor but not CD59 limits experimental immune-complex glomerulonephritis.
    Bao L, Haas M, Minto AW, Quigg RJ.
    Lab Invest; 2007 Apr 15; 87(4):357-64. PubMed ID: 17259999
    [Abstract] [Full Text] [Related]

  • 20. Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.
    Welch TR, Frenzke M, Carroll MC, Witte DP.
    Clin Immunol; 2001 Dec 15; 101(3):366-70. PubMed ID: 11726230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.